Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on prevention of stroke: Which one is better?

被引：0

作者：

Xiao, Lin ^{[1
]}

Ouyang, Haichun ^{[2
]}

Su, Qiwen ^{[1
]}

Huang, Yuli ^{[2
]}

机构：

[1] First Peoples Hosp Shunde, Xingtan Affiliated Hosp, Dept Internal Med, Foshan 528300, Peoples R China

[2] First Peoples Hosp Shunde, Dept Cardiol, Penglai Rd, Foshan 528300, Peoples R China

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2016年 / 223卷

关键词：

Angiotensin-converting enzyme inhibitors; Angiotensin II receptor blockers; Stroke; Hypertension; MYOCARDIAL-INFARCTION; SYSTEM INHIBITORS; HYPERTENSION; RISK; MORTALITY;

D O I：

10.1016/j.ijcard.2016.08.150

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：56 / 57

页数：2

共 14 条

[1]

[Anonymous], 2015, J AM HEART ASSOC, DOI DOI 10.1161/JAHA.114.001519

[2] Impact of renin-angiotensin system inhibitors on mortality and major cardiovascular endpoints in hypertension: A number-needed-to-treat analysis [J].

Brugts, Jasper J. ;

van Vark, Laura ;

Akkerhuis, Martijn ;

Bertrand, Michel ;

Fox, Kim ;

Mourad, Jean-Jacques ;

Boersma, Eric .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 181 :425-429

[3]

CHOBANIAN AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI DOI 10.1161/01.HYP.0000107251.49515.C2

[4]

Liu Li-Sheng, 2011, Zhonghua Xin Xue Guan Bing Za Zhi, V39, P579

[5] 2013 ESH/ESC Guidelines for themanagement of arterial hypertension The Task Force for the management ofarterial hypertension of the European Society ofHypertension (ESH) and of the European Society of Cardiology (ESC) [J].

Mancia, Giuseppe ;

Fagard, Robert ;

Narkiewicz, Krzysztof ;

Redon, Josep ;

Zanchetti, Alberto ;

Boehm, Michael ;

Christiaens, Thierry ;

Cifkova, Renata ;

De Backer, Guy ;

Dominiczak, Anna ;

Galderisi, Maurizio ;

Grobbee, Diederick E. ;

Jaarsma, Tiny ;

Kirchhof, Paulus ;

Kjeldsen, Sverre E. ;

Laurent, Stephane ;

Manolis, Athanasios J. ;

Nilsson, Peter M. ;

Ruilope, Luis Miguel ;

Schmieder, Roland E. ;

Sirnes, Per Anton ;

Sleight, Peter ;

Viigimaa, Margus ;

Waeber, Bernard ;

Zannad, Faiez ;

Redon, Josep ;

Dominiczak, Anna ;

Narkiewicz, Krzysztof ;

Nilsson, Peter M. ;

Burnier, Michel ;

Viigimaa, Margus ;

Ambrosioni, Ettore ;

Caufield, Mark ;

Coca, Antonio ;

Olsen, Michael Hecht ;

Schmieder, Roland E. ;

Tsioufis, Costas ;

van de Borne, Philippe ;

Zamorano, Jose Luis ;

Achenbach, Stephan ;

Baumgartner, Helmut ;

Bax, Jeroen J. ;

Bueno, Hector ;

Dean, Veronica ;

Deaton, Christi ;

Erol, Cetin ;

Fagard, Robert ;

Ferrari, Roberto ;

Fagard, David Hasdai ;

Hoes, Arno W. .

JOURNAL OF HYPERTENSION, 2013, 31 (07) :1281-1357

[6]

Ng LP, 2014, SINGAP MED J, V55, P146

[7] Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study [J].

O'Donnell, Martin J. ;

Xavier, Denis ;

Liu, Lisheng ;

Zhang, Hongye ;

Chin, Siu Lim ;

Rao-Melacini, Purnima ;

Rangarajan, Sumathy ;

Islam, Shofiqul ;

Pais, Prem ;

McQueen, Matthew J. ;

Mondo, Charles ;

Damasceno, Albertino ;

Lopez-Jaramillo, Patricio ;

Hankey, Graeme J. ;

Dans, Antonio L. ;

Yusoff, Khalid ;

Truelsen, Thomas ;

Diener, Hans-Christoph ;

Sacco, Ralph L. ;

Ryglewicz, Danuta ;

Czlonkowska, Anna ;

Weimar, Christian ;

Wang, Xingyu ;

Yusuf, Salim .

LANCET, 2010, 376 (9735) :112-123

[8] Angiotensin receptor blockers (ARB) outperform angiotensin-converting enzyme (ACE) inhibitors on ischemic stroke prevention in patients with hypertension and diabetes - A real-world population study in Taiwan [J].

Pai, Pei-Ying ;

Muo, Chih-Hsin ;

Sung, Fung-Chang ;

Ho, Hung-Chi ;

Lee, Yuan-Teh .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 215 :114-119

[9] Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both [J].

Pfeffer, MA ;

McMurray, JJV ;

Velazquez, EJ ;

Rouleau, JL ;

Kober, L ;

Maggioni, AP ;

Solomon, SD ;

Swedberg, K ;

Van de Werf, F ;

White, H ;

Leimberger, JD ;

Henis, M ;

Edwards, S ;

Zelenkofske, S ;

Sellers, MA ;

Califf, RM ;

Aylward, P ;

Armstrong, P ;

Barvik, S ;

Belenkov, Y ;

Dalby, A ;

Diaz, R ;

Drexler, H ;

Ertl, G ;

Francis, G ;

Hampton, J ;

Harsanyi, A ;

Kvasnicka, J ;

Mareev, V ;

Marin-Neto, J ;

Murin, J ;

Myers, M ;

Nordlander, R ;

Opolski, G ;

Soler-Soler, J ;

Spac, J ;

Stefenelli, T ;

Sugrue, D ;

Van Gilst, W ;

Varshavsky, S ;

Weaver, D ;

Zannad, F ;

Aguilar, D ;

Alvarez, A ;

Al-Taweel, M ;

Anavekar, N ;

Finn, P ;

Lopez-Jimenez, F ;

Mercier, R ;

Lewis, E .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (20) :1893-1906

[10] Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis [J].

Reboldi, Gianpaolo ;

Angeli, Fabio ;

Cavallini, Claudio ;

Gentile, Giorgio ;

Mancia, Giuseppe ;

Verdecchia, Paolo .

JOURNAL OF HYPERTENSION, 2008, 26 (07) :1282-1289

← 1 2 →